IDIBELL on the media
Alterations in the blood immune system found to increase cancer risk
An international team of researchers identifies the genetic basis and biological processes that influence cancer risk related to alterations in the number of immune cells present in blood.
IDIBELL’s scientific community will once again claim the role of women and girls in science
The event will take place at the Barradas Auditorium in L’Hospitalet de Llobregat on Thursday, February 8, at 7 p.m. In its 7th edition, the sLHam will once again be starred by six scientists from IDIBELL and two sLHamers from the Bellvitge Institute: a student and a science teacher.
Type 2 diabetes linked to increased depressive symptoms
A research team has shown how the presence of type 2 diabetes increased the likelihood of more depressive symptoms, and in turn, the higher the levels of depressive symptoms, the higher the prevalence of type 2 diabetes.
The UICEC renews its participation in the ISCIII Clinical Research Support Platform until 2026
This grant allows the UICEC to remain one of the 27 clinical research support units that make up the ISCIII platform.
Viladecans Contra el Càncer gives 35,000 euros to IDIBELL for research on melanomas, gynecological cancers and nutrition
The association based in the Baix Llobregat has been collaborating with IDIBELL since 2016, collecting funds for cancer research.
The Ministry of Science and Innovation awards €4 million for the Phase 2b clinical trial with a new drug for ischemic stroke
Collaborative success in advancing stroke neuroprotection
Environmental exposures and social determinants are key in patients with pulmonary fibrosis
The renowned Dr. Kerri Johannson, a member of the Snyder Institute for Chronic Diseases at Canada’s University of Calgary, gave an IDIBELL seminar on January 12 at the Bellvitge Campus on the impact of environmental exposures on patients with pulmonary fibrosis.
Scientists present an oncolytic virus targeting NK cells with great antitumor potential
A research group from IDIBELL and ICO have presented an oncolytic virus that stimulates the anti-tumor response of NK cells and helps slow the growth of cancer.
Scientists find a new mechanism that explains the development of vascular malformations
A study published in Circulation offers unprecedented perspectives on the molecular mechanisms that lead to Hereditary Hemorrhagic Telangiectasia
The ”la Caixa” Foundation and Barcelona City Council collaborate with IDIBELL and ICO in an innovative project to fight sedentary lifestyle
It is one of the winning initiatives of the 2023 call for grants, which is the result of a collaboration agreement between the charity institution and the council.